Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASASemaglutide, the drug behind Ozempic and Wegovy, may have benefits that extend well beyond weight loss and diabetes. In a large Swedish study of nearly 15,000 people with bipolar disorder, its use was linked to a 21% lower risk of psychiatric hospitalization. Researchers think effects on inflammation and brain-related biological pathways could help stabilize mood, though other GLP-1 drugs did not show the same association.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | AI uncovers hidden Ozempic side effects across 400,000 Reddit posts | 0 | 10.41 | 13-09-2026 |
| 2 | Ozempic and similar medicines increase risk of hair loss in men | 0 | 7.72 | 03-09-2026 |
| 3 | GLP-1-driven vitamin deficiency linked to rare brain disorder: Study | 0 | 10.4 | 12-09-2026 |
| 4 | Qu'est-ce que le phénomène du "divorce Ozempic" ? "Le partenaire peut commencer à se sentir en insécurité" | 0 | 9.86 | 22-09-2026 |
| 5 | У популярного препарата обнаружили способность сокращать тягу к алкоголю | 0 | 9 | 01-10-2026 |
| 6 | Medicare expands availability for GLP-1 weight loss drugs. A KU doctor explains what to know | 0 | 7.53 | 29-07-2026 |
| 7 | GLP-1s Could Change More Than Your Appetite: What We Know About Their Impact on ADHD, Brain Health and Libido | 0 | 6.29 | 14-09-2026 |
| 8 | Más allá de la pérdida de peso: los fármacos para adelgazar reducen las enfermedades del corazón | 0 | 6.03 | 25-09-2026 |
| 9 | Menos ultraprocesados y más fruta: así comen ahora los usuarios de fármacos para perder peso | 0 | 6.64 | 29-09-2026 |